Anika Therapeutics (ANIK) Prepaid Assets (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Prepaid Assets of $3.2 million for Q2 2026, down 40.24% year-over-year from $5.3 million in Q2 2025, and down 19.92% quarter-over-quarter from $3.9 million in Q1 2026.
Anika Therapeutics (ANIK) Prepaid Assets (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Prepaid Assets for 17 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Prepaid Assets fell 40.24% year-over-year to $3.2 million; the TTM figure through Jun 2026 stood at $3.2 million (down 40.24% YoY), while the FY2025 annual figure was $3.4 million, down 38.11% from the prior year.
- Prepaid Assets slipped to $3.2 million in Q2 2026 per ANIK's latest filing, from $3.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $10.5 million in Q1 2022 and bottomed at $3.2 million in Q2 2026.
- Historically, Prepaid Assets has averaged $6.8 million across 5 years, with a median of $7.2 million in 2023.
- Annual changes were most pronounced in 2022 — Prepaid Assets grew 15.42% — and 2026, when it tumbled 40.24%.
- Anika Therapeutics' Prepaid Assets stood at $8.8 million in 2022, then retreated by 15.31% to $7.5 million in 2023, then declined by 26.51% to $5.5 million in 2024, then sank by 38.11% to $3.4 million in 2025, then fell by 7.32% to $3.2 million in 2026.
- Business Quant data shows ANIK's Prepaid Assets at $3.2 million in Q2 2026, $3.9 million in Q1 2026, and $3.4 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.15 Mn |
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 5.13 Mn |
| Jun 30, 2025 | 5.27 Mn |
| Mar 31, 2025 | 5.82 Mn |
| Dec 31, 2024 | 5.49 Mn |
| Sep 30, 2024 | 5.75 Mn |
| Jun 30, 2024 | 6.94 Mn |
| Mar 31, 2024 | 8.85 Mn |
| Dec 31, 2023 | 7.48 Mn |
| Sep 30, 2023 | 7.72 Mn |
| Jun 30, 2023 | 7.79 Mn |
| Mar 31, 2023 | 8.65 Mn |
| Dec 31, 2022 | 8.83 Mn |
| Sep 30, 2022 | 8.58 Mn |
| Jun 30, 2022 | 8.96 Mn |
| Mar 31, 2022 | 10.46 Mn |
| Dec 31, 2021 | 8.29 Mn |
| Sep 30, 2021 | 7.43 Mn |